---
$id: https://graph.org.ai/products/commodity/51351602
$type: Product
source: UNSPSC
code: "51351602"
title: "Aglepristone"
class: "51351600"
classTitle: "Estrogen, progestin, or internal contraceptive estrenes"
family: "51350000"
familyTitle: "Estrogens and progestins and internal contraceptives"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Aglepristone

**UNSPSC Code**: 51351602
**Class**: [Estrogen, progestin, or internal contraceptive estrenes](Estrogen, progestin, or internal contraceptive estrenes.mdx)
**Family**: [Estrogens and progestins and internal contraceptives](../Estrogens and progestins and internal contraceptives.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-progestin, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0UT4JLE1CM. European Medicines Agency schedules Aglepristone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05285MIG. Aglepristone generally arises in the molecular formula C29H37NO2. The term AGLEPRISTONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 no. 3 1994, list 34.) AGLEPRISTONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule aglepristone under HS 29225000 and SITC 51467. As of Q4 2014, AGLEPRISTONE remains the US FDA Preferred Term for this commodity. Aglepristone bears US NLM identifiers UMLS ID C0963581 and NCI Concept Code C78092. SMILES: OC1(C2(C(C3C(=C4C(=CC(=O)CC4)CC3)C(C2)c2ccc(N(C)C)cc2)CC1)C)/C=C\C.

